IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery

Regulatory News:

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced the signing of a partnership agreement with 8i Robotics Inc. The first milestone of this agreement focuses on clinical research aimed at achieving European regulatory compliance for a surgeon-supervised robot designed for spine surgery.

IMPLANET to exhibit alongside 8i Robotics Inc. at the NASS¹ Annual Meeting (booth #1037) in Denver

Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: "As part of our strategic plan, the signing of this partnership agreement with 8i Robotics Inc., a Canadian manufacturer and innovative player in the field of robotics, places IMPLANET at the core of clinical evaluation and regulatory registration in Europe of a world unique robotic solution. The technical solutions developed by 8i Robotics represent the next step in surgeon-supervised assistance technologies, enabling more efficient robotic procedures and enhanced patient safety. This new commitment should allow us to quickly conclude additional clinical research agreements with leading hospitals in France to complete the regulatory registration of implantable solutions dedicated to robotics on the European market.”

Dr. Brent Bailey, Systems Engineer at 8i Robotics and a veteran medical device developer in surgical microscopy, stated: “The 8i Robotics solution delivers precise implant placement while minimizing complications by enabling accurate navigation to the surgical site. Its compact design, positioned on one side of the surgical table, ensures that clinical staff remain unobstructed and allows seamless integration of intraoperative imaging tools. We look forward to working with IMPLANET and our partners to achieve the CE mark and support surgeons in Europe.”

This clinical and regulatory partnership between IMPLANET and 8i Robotics will enable research with leading French hospitals and preparing CE mark of a groundbreaking robotic solution in Europe. It is integral to IMPLANET’S long-term strategic commercial offering to combine the latest advancements and innovations in spinal surgery (deformity correction systems, minimally invasive product ranges, robotics, artificial intelligence, etc.) for the global market.